Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

Peer Review reports

Original Submission
23 Apr 2017	Submitted	Original manuscript
15 May 2017	Reviewed	Reviewer Report - Yoann Madec
18 May 2017	Reviewed	Reviewer Report - Habib Ramadhani
4 Jul 2017	Author responded	Author comments - Victor Ssempijja
Resubmission - Version 2
4 Jul 2017	Submitted	Manuscript version 2
10 Aug 2017	Author responded	Author comments - Victor Ssempijja
Resubmission - Version 3
10 Aug 2017	Submitted	Manuscript version 3
Publishing
13 Aug 2017	Editorially accepted
22 Aug 2017	Article published	10.1186/s12879-017-2680-6

Back to article page